1-7 of 7
Yueyun Lai
Close
Sort by
Journal Articles

Cancer-Related Gene Mutations Drive Resistance to the Third-Generation Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukaemia

Xiaoshuai Zhang, Zongru Li, Ya-Zhen Qin, Robert Peter Gale, Yueyun Lai, Hongxia Shi, Xiao Jun Huang, Qian Jiang
Journal: Blood
Blood (2022) 140 (Supplement 1): 9611–9613.
https://doi.org/10.1182/blood-2022-169397
Published: 2022
Journal Articles

The Application of Decitabine in Combination with G-CSF, Low-Dose Cytarabine and Aclarubicin in AML-MRC: A Single Center Case Control Study

Hao Jiang, Jing Liu, Xiaohong Liu, Jinsong Jia, Lizhong Gong, Shengye Lu, Xiaojun Huang, Jing Wang, Xiaosu Zhao, Yueyun Lai, Hongxia Shi, Yingjun Chang, Guorui Ruan
Journal: Blood
Blood (2021) 138 (Supplement 1): 2320.
https://doi.org/10.1182/blood-2021-149493
Published: 2021
Journal Articles

Mutations Based on Next-Generation Sequencing May be Complementally to Prognostic Risk in Myelodysplastic Syndromes

Jing Wang, MD, Jinsong Jia, Xiaohong Liu, Lizhong Gong, Shengye Lu, Yu Wang, Lanping Xu, Xiaohui Zhang, Chenhua Yan, Yueyun Lai, Xiaosu Zhao, PhD, Yazhen Qin, Guorui Ruan, Yingjun Chang, Hongxia Shi, Kaiyan Liu, Xiaojun Huang, Hao Jiang, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 42–43.
https://doi.org/10.1182/blood-2020-140977
Published: 2020
Journal Articles

Comparable Efficacy and Safety of Chinese Generic Imatinib and Branded Imatinib in Patients with Newly Diagnosed Chronic Myeloid Leukemia: A Retrospective Study

Xuelin Dou, Yazhen Qin, Yueyun Lai, Hongxia Shi, Xiaojun Huang, MD, Qian Jiang, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2940.
https://doi.org/10.1182/blood-2019-130081
Published: 2019
Journal Articles

Philadelphia-Positive Leukemia Patients With The Y253H Or F359V Mutations Have a High Risk Of Developing New Mutations In The Setting Of Dasatinib Resistance

Qian Jiang, Yazhen Qin, Yueyun Lai, Hao Jiang, Jing Wang, Hongxia Shi, MD, Xiaojun Huang, M.D Ph.D
Journal: Blood
Blood (2013) 122 (21): 5188.
https://doi.org/10.1182/blood.V122.21.5188.5188
Published: 2013
Journal Articles

Efficacy Analysis With Imatinib Monotherapy Was Superior To Allogeneic Hematopoietic Stem Transplantation In Pediatric Patients With Chronic Phase Of Chronic Myelogenous Leukemia

Hao Jiang, Daihong Liu, Lanping Xu, Kaiyan Liu, Shanshan Chen, MD, Bin Jiang, MD, Qian Jiang, Huan Chen, Yuhong Chen, Wei Han, MD, Xiaohui Zhang, Yazhen Qin, Yueyun Lai, Yanrong Liu, MD, PhD, Xiaojun Huang
Journal: Blood
Blood (2013) 122 (21): 4035.
https://doi.org/10.1182/blood.V122.21.4035.4035
Published: 2013
Journal Articles

Comparison of Response Over 6 Years Between Patients with Chronic Myeloid Leukemia Who Received Imatinib as Initial Therapy and Those Who Received Imatinib as Secondary Therapy.

Hao Jiang, MD, Xiaojun Huang, MD, PhD, Shanshan Chen, MD, Bin Jiang, Qian Jiang, PhD, Yazhen Qin, Yueyun Lai
Journal: Blood
Blood (2009) 114 (22): 4281.
https://doi.org/10.1182/blood.V114.22.4281.4281
Published: 2009